DANAHER CORPORATION

DHR Q1 2026 institutional ownership is a $100.7B book across 2,092 holders. Capital Research Global Investors moved from a de minimis $576K position to $1.69B (8.9M shares, ~+2,773%, +$1.55B) -- the most aggressive single-quarter build in this dataset. Holocene Advisors built from $940K to $766M (4.0M shares, +586%, +$551M). BlackRock is the largest holder at $9.8B (51.6M shares, -2.2%, -$2.13B) -- the largest seller. State Street $5.3B (27.9M shares, +3.5%, +$1.05B despite fewer shares). JPMorgan $3.1B (16.9M shares, -8.5%, -$1.83B). Wellington Management $2.8B (14.8M shares, -2.2%, -$650M). Geode Capital $2.7B (14.1M shares, +3.5%). Capital International Investors $2.7B (14.0M shares, -7.7%, -$1.52B). Vanguard Capital Management $7.8B (41.1M shares, NEW); Vanguard Portfolio Management $2.6B (13.9M shares, NEW). Morgan Stanley $2.1B (11.2M shares, +2.9%). FMR LLC $4.3B (22.5M shares, +9.9%, +$193M). Generation Investment Management $1.4B (7.3M shares, -2.4%, -$358M). Northern Trust $1.3B (7.1M shares, -2.4%). Eagle Capital $1.2B (6.6M shares, +2.6%). Bank of America $1.2B (6.3M shares, -2.8%, -$325M). Janus Henderson $1.2B (6.5M shares, -2.7%, -$327M). Nuveen $1.0B (5.3M shares, -4.9%, -$267M). UBS AM $991M (5.2M shares, +3.1%, +$156M). Goldman Sachs $887M (4.7M shares, -2.5%). Schwab $898M (4.7M shares, +3.4%, +$152M). BNY Mellon $726M (3.8M shares, -8.1%, -$356M). New positions: Vanguard two. The 75.50 whaleScore reflects AUM. Smart-money read: defining rotation. Capital Research+$1.55B and Holocene Advisors+$551M represent high-conviction active-manager front-running -- these patterns historically precede biopharma catalyst events (M&A, pipeline successes, spin announcements). The simultaneous -$2.13B from BlackRock and -$1.83B from JPMorgan signals passive/custodial reallocation rather than fundamental thesis change. Net read: cautiously bullish -- the extreme concentration of new money into Capital Research suggests a pending catalyst that large active managers are front-running.